NCT00231764 - MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients | Biotech Hunter

Enrollment

1,760

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

May 31, 2006

Study Completion Date

February 29, 2008

Conditions

Kidney Transplantation

Interventions

DRUG

daclizumab

All Listed Sponsors

collaborator

Prof. Philip Halloran, Edmonton, Canada (sponsor)

UNKNOWN

collaborator

Prof. Yves Vanrenterghem, Leuven, Belgium (Steering Committee Member)

UNKNOWN

collaborator

Prof. Pierre Daloze, Montréal, Canada (Steering Committee Member)

UNKNOWN

collaborator

Prof. Thomas C. Pearson, Atlanta, USA (Steering Committee Member)

UNKNOWN

collaborator

Prof. Ulrich Frei, Berlin, Germany (Steering Committee Member)

UNKNOWN

collaborator

Prof. Flavio Vincenti, San Francisco, USA (Ass. Steering Committee Member)

UNKNOWN

collaborator

Prof. Josep Grinyo, Barcelona, Spain (Ass. Steering Committee Member)

UNKNOWN

collaborator

Hoffmann-La Roche

INDUSTRY

lead

Ekberg, Henrik, M.D.

INDIV